These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 29133484)
1. Loss of E-cadherin provides tolerance to centrosome amplification in epithelial cancer cells. Rhys AD; Monteiro P; Smith C; Vaghela M; Arnandis T; Kato T; Leitinger B; Sahai E; McAinsh A; Charras G; Godinho SA J Cell Biol; 2018 Jan; 217(1):195-209. PubMed ID: 29133484 [TBL] [Abstract][Full Text] [Related]
2. IFT proteins interact with HSET to promote supernumerary centrosome clustering in mitosis. Vitre B; Taulet N; Guesdon A; Douanier A; Dosdane A; Cisneros M; Maurin J; Hettinger S; Anguille C; Taschner M; Lorentzen E; Delaval B EMBO Rep; 2020 Jun; 21(6):e49234. PubMed ID: 32270908 [TBL] [Abstract][Full Text] [Related]
3. HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients. Pannu V; Rida PC; Ogden A; Turaga RC; Donthamsetty S; Bowen NJ; Rudd K; Gupta MV; Reid MD; Cantuaria G; Walczak CE; Aneja R Oncotarget; 2015 Mar; 6(8):6076-91. PubMed ID: 25788277 [TBL] [Abstract][Full Text] [Related]
4. When E-cadherin is away, centrosomes can play. Vargas-Hurtado D; Basto R J Cell Biol; 2018 Jan; 217(1):11-13. PubMed ID: 29259095 [TBL] [Abstract][Full Text] [Related]
5. KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries. Pawar S; Donthamsetty S; Pannu V; Rida P; Ogden A; Bowen N; Osan R; Cantuaria G; Aneja R J Ovarian Res; 2014; 7():53. PubMed ID: 25028599 [TBL] [Abstract][Full Text] [Related]
6. Centrosome Clustering Is a Tumor-selective Target for the Improvement of Radiotherapy in Breast Cancer Cells. Choe MH; Kim J; Ahn J; Hwang SG; Oh JS; Kim JS Anticancer Res; 2018 Jun; 38(6):3393-3400. PubMed ID: 29848688 [TBL] [Abstract][Full Text] [Related]
7. Using Cell Culture Models of Centrosome Amplification to Study Centrosome Clustering in Cancer. Kwon M Methods Mol Biol; 2016; 1413():367-92. PubMed ID: 27193861 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic alterations impede epithelial-mesenchymal transition by modulating centrosome amplification and Myc/RAS axis in triple negative breast cancer cells. Das L Sci Rep; 2023 Feb; 13(1):2458. PubMed ID: 36774386 [TBL] [Abstract][Full Text] [Related]
10. A look into the link between centrosome amplification and breast cancer. Zhang Y; Tian J; Qu C; Peng Y; Lei J; Sun L; Zong B; Liu S Biomed Pharmacother; 2020 Dec; 132():110924. PubMed ID: 33128942 [TBL] [Abstract][Full Text] [Related]
11. Kolavenic acid analog restores growth in HSET-overproducing fission yeast cells and multipolar mitosis in MDA-MB-231 human cells. Kurisawa N; Yukawa M; Koshino H; Onodera T; Toda T; Kimura KI Bioorg Med Chem; 2020 Jan; 28(1):115154. PubMed ID: 31753800 [TBL] [Abstract][Full Text] [Related]
12. Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction. Kalkan BM; Ozcan SC; Cicek E; Gonen M; Acilan C Cell Death Dis; 2024 Mar; 15(3):222. PubMed ID: 38493150 [TBL] [Abstract][Full Text] [Related]
13. Acentrosomal spindle organization renders cancer cells dependent on the kinesin HSET. Kleylein-Sohn J; Pöllinger B; Ohmer M; Hofmann F; Nigg EA; Hemmings BA; Wartmann M J Cell Sci; 2012 Nov; 125(Pt 22):5391-402. PubMed ID: 22946058 [TBL] [Abstract][Full Text] [Related]
14. A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells. Fielding AB; Lim S; Montgomery K; Dobreva I; Dedhar S Oncogene; 2011 Feb; 30(5):521-34. PubMed ID: 20838383 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of kinesin motor protein KIFC1 by AZ82 induces multipolar mitosis and apoptosis in prostate cancer cell. Parvin A; Hao SL; Tan FQ; Yang WX Gene; 2020 Nov; 760():144989. PubMed ID: 32717307 [TBL] [Abstract][Full Text] [Related]
17. Kinesins regulate the heterogeneity in centrosome clustering after whole-genome duplication. Lau TT; Ma HT; Poon RY Life Sci Alliance; 2024 Oct; 7(10):. PubMed ID: 39074902 [TBL] [Abstract][Full Text] [Related]
18. Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification. Saatci O; Akbulut O; Cetin M; Sikirzhytski V; Uner M; Lengerli D; O'Quinn EC; Romeo MJ; Caliskan B; Banoglu E; Aksoy S; Uner A; Sahin O Cell Death Differ; 2023 May; 30(5):1305-1319. PubMed ID: 36864125 [TBL] [Abstract][Full Text] [Related]
19. Discovery of 2-(3-Benzamidopropanamido)thiazole-5-carboxylate Inhibitors of the Kinesin HSET (KIFC1) and the Development of Cellular Target Engagement Probes. Saint-Dizier F; Matthews TP; Gregson AM; Prevet H; McHardy T; Colombano G; Saville H; Rowlands M; Ewens C; McAndrew PC; Tomlin K; Guillotin D; Mak GW; Drosopoulos K; Poursaitidis I; Burke R; van Montfort R; Linardopoulos S; Collins I J Med Chem; 2023 Feb; 66(4):2622-2645. PubMed ID: 36749938 [TBL] [Abstract][Full Text] [Related]